Actively Recruiting
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
Led by Boston University · Updated on 2025-07-30
266
Participants Needed
2
Research Sites
138 weeks
Total Duration
On this page
Sponsors
B
Boston University
Lead Sponsor
N
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
CONDITIONS
Official Title
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Give informed consent and sign a consent form in REDCap
- Willing to follow all study procedures and be available for the study duration
- Able to read in English or Spanish
- Be a dental patient at one of the participating community health centers
- Have at least one HIV risk factor such as men having sex with men, multiple sex partners, or intravenous drug use
You will not qualify if you...
- Self-report having HIV infection
- Currently participating in another HIV or text message study
- A woman who reports having sex only with women
- Does not have a mobile phone or device that can receive study text messages
- Does not have unlimited texting on their mobile plan
- Has not used text messaging at least once in the past month
- Has a low literacy screening score of 2 or below
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
South End Community Health Center
Boston, Massachusetts, United States, 02118
Actively Recruiting
2
East Boston Neighborhood Health Center
Boston, Massachusetts, United States, 02128
Actively Recruiting
Research Team
M
Michelle Henshaw, DDS, MPH
CONTACT
G
Gabriel Federo Hungria, MD, MSCR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here